Integrated Cardiac Safety

The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug’s cardiac safety profile a high priority during both development and post-approval monitoring. <i>Integrated Cardiac Safety</i> provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug’s life, from discovery and development through postmarketing research. This self-contained, reader-friendly text is valuable to professionals in the pharmaceutical, biotechnology, and CRO industries, pharmacologists, toxicologists, government officials, and students.